• Adaptogenics appointed Antoun Nabhan as president, effective Oct. 1, 2026.
• Nabhan brings nearly two decades in healthcare investment, corporate finance, business development; advised on more than $2 billion in transactions.
• He previously served as senior vice president at Oaktree Capital Management, later managed a public healthcare equities portfolio at Sagamore Bioventures.
• Operating roles include CFO at Establishment Labs, vice president of corporate development at Pear Therapeutics, Raptor Pharmaceuticals, Capnia.
• Mandate includes leading asset acquisitions, licensing partnerships, strategic collaborations, working with CEO J. David Warren on deal structure and capital planning.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptogenics Health Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202610130730TNWSWRCACNPR_____1kZaFy1ge) on October 13, 2026, and is solely responsible for the information contained therein.